A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice
- 1 October 2018
- journal article
- letter
- Published by Springer Science and Business Media LLC in Science China Life Sciences
- Vol. 61 (10), 1280-1282
- https://doi.org/10.1007/s11427-018-9343-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pathogen genomic surveillance elucidates the origins, transmission and evolution of emerging viral agents in ChinaScience China Life Sciences, 2017
- Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus InfectionScientific Reports, 2016
- Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infectionAntiviral Research, 2016
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal AntibodiesJournal of Virology, 2014
- A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoVVirology Journal, 2013
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaThe New England Journal of Medicine, 2012
- Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigenNature Protocols, 2009